NZ334992A - Meningococcus vaccine comprising the valence of BZ83 strain - Google Patents

Meningococcus vaccine comprising the valence of BZ83 strain

Info

Publication number
NZ334992A
NZ334992A NZ334992A NZ33499298A NZ334992A NZ 334992 A NZ334992 A NZ 334992A NZ 334992 A NZ334992 A NZ 334992A NZ 33499298 A NZ33499298 A NZ 33499298A NZ 334992 A NZ334992 A NZ 334992A
Authority
NZ
New Zealand
Prior art keywords
gly
ala
lys
ser
thr
Prior art date
Application number
NZ334992A
Other languages
English (en)
Inventor
Marie-Jose Quentin-Millet
Bachra Rokbi
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of NZ334992A publication Critical patent/NZ334992A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NZ334992A 1997-08-07 1998-08-03 Meningococcus vaccine comprising the valence of BZ83 strain NZ334992A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9710301A FR2767060B1 (fr) 1997-08-07 1997-08-07 Vaccin meningocoque comportant la valence de souche bz83

Publications (1)

Publication Number Publication Date
NZ334992A true NZ334992A (en) 2001-09-28

Family

ID=9510254

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ334992A NZ334992A (en) 1997-08-07 1998-08-03 Meningococcus vaccine comprising the valence of BZ83 strain

Country Status (10)

Country Link
EP (1) EP0948534A1 (de)
JP (1) JP2001503068A (de)
CN (1) CN1241193A (de)
AU (1) AU8987598A (de)
CA (1) CA2267066A1 (de)
FR (1) FR2767060B1 (de)
HU (1) HUP0001451A3 (de)
NO (1) NO991558L (de)
NZ (1) NZ334992A (de)
WO (1) WO1999007741A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107219D0 (en) * 2001-03-22 2001-05-16 Microbiological Res Authority Immunogenic commensal neisseria sequences
JP2016539950A (ja) * 2013-12-02 2016-12-22 ビー． シュライバーズ，アンソニー 細菌表面受容体タンパク質由来の免疫原性組成物およびワクチン
WO2016091902A1 (en) * 2014-12-09 2016-06-16 Sanofi Pasteur Compositions comprising n. meningitidis proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
FR2739624B1 (fr) * 1995-10-10 1997-12-05 Pasteur Merieux Serums Vacc Nouvelle sous-unite tbp2 de neisseria meningitidis

Also Published As

Publication number Publication date
NO991558D0 (no) 1999-03-30
JP2001503068A (ja) 2001-03-06
HUP0001451A3 (en) 2001-09-28
EP0948534A1 (de) 1999-10-13
CA2267066A1 (en) 1999-02-18
NO991558L (no) 1999-03-30
WO1999007741A1 (fr) 1999-02-18
FR2767060A1 (fr) 1999-02-12
AU8987598A (en) 1999-03-01
FR2767060B1 (fr) 2000-02-11
CN1241193A (zh) 2000-01-12
HUP0001451A2 (hu) 2001-04-28

Similar Documents

Publication Publication Date Title
Maciver et al. Identification of an outer membrane protein involved in utilization of hemoglobin-haptoglobin complexes by nontypeable Haemophilus influenzae
EP0749322A1 (de) -i(H. PYLORI) DEFIZIERT AN BLASEN-BILDENDEM TOXIN UND ENTSPRECHENDE METHODASE
US20100143412A1 (en) Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
US6617128B2 (en) Nucleic acid molecules encoding proteins which impart the adhesion of neisseria cells to human cells
NZ334992A (en) Meningococcus vaccine comprising the valence of BZ83 strain
WO1999055871A1 (en) Polypeptides from moraxella (branhamella) catarrhalis
US7592158B2 (en) BASB019 proteins and genes from Moraxella catarrhalis, antigens, antibodies, and uses
JP4503175B2 (ja) モラクセラ・カタラーリス（Ｍｏｒａｘｅｌｌａｃａｔａｒｒｈａｌｉｓ）由来の化合物
EP1082436B1 (de) Moraxella catarrhalis pilq proteine
US7432366B2 (en) Moraxella catarrhalis BASB034 polypeptides and used thereof
US20030170261A1 (en) Virulence genes, proteins, and their use
JP2003506027A (ja) モラクセラ・カタラーリス（Ｍｏｒａｘｅｌｌａｃａｔａｒｒｈａｌｉｓ）のＢＡＳＢ１１４抗原およびその使用
JP2003506045A (ja) モラクセラ・カタラーリス（Ｍｏｒａｘｅｌｌａｃａｔａｒｒｈａｌｉｓ）由来のＢＡＳＢ１１９ポリペプチドおよびポリヌクレオチド
ZA200007108B (en) BASB027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses.

Legal Events

Date Code Title Description
PSEA Patent sealed